Capstone Capital Management Ltd lifted its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 17.8% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,911 shares of the semiconductor company’s stock after purchasing an additional 2,560 shares during the quarter. Synopsys comprises 2.9% of Capstone Capital Management Ltd’s portfolio, making the stock its 3rd biggest holding. Capstone Capital Management Ltd’s holdings in Synopsys were worth $7,355,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the company. AMI Asset Management Corp increased its stake in Synopsys by 56.1% in the third quarter. AMI Asset Management Corp now owns 80,884 shares of the semiconductor company’s stock worth $35,179,000 after purchasing an additional 29,065 shares during the period. Kapitalo Investimentos Ltda purchased a new stake in shares of Synopsys in the third quarter valued at approximately $333,000. Bank Pictet & Cie Europe AG grew its position in shares of Synopsys by 176.6% during the 3rd quarter. Bank Pictet & Cie Europe AG now owns 2,545 shares of the semiconductor company’s stock worth $1,107,000 after buying an additional 1,625 shares in the last quarter. Norway Savings Bank raised its holdings in shares of Synopsys by 7.3% in the third quarter. Norway Savings Bank now owns 2,211 shares of the semiconductor company’s stock valued at $962,000 after acquiring an additional 150 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Synopsys by 2.7% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 58,644 shares of the semiconductor company’s stock worth $25,507,000 after acquiring an additional 1,534 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have weighed in on SNPS shares. Needham & Company LLC upped their target price on Synopsys from $580.00 to $620.00 and gave the stock a “buy” rating in a report on Monday, October 12th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $558.00 to $560.00 in a report on Thursday, August 27th. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $640.00 price objective (up from $590.00) on shares of Synopsys in a report on Thursday, October 1st. Finally, JPMorgan Chase & Co. decreased their price target on Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $575.00.
Check Out Our Latest Stock Report on SNPS
Insider Transactions at Synopsys
In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of the business’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer directly owned 22,717 shares in the company, valued at approximately $11,358,500. The trade was a 28.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction on Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the sale, the insider directly owned 120,421 shares in the company, valued at approximately $53,197,180.96. This trade represents a 17.19% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 117,163 shares of company stock worth $51,366,457 over the last three months. 0.56% of the stock is owned by insiders.
Synopsys Stock Performance
NASDAQ SNPS opened at $447.62 on Wednesday. The firm has a market capitalization of $85.78 billion, a P/E ratio of 79.08, a PEG ratio of 1.85 and a beta of 1.21. The stock has a 50-day simple moving average of $429.16 and a two-hundred day simple moving average of $442.69. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 10.97 earnings per share for the current year.
Synopsys announced that its board has approved a stock buyback plan on Monday, October 5th that permits the company to buy back $1.00 billion in outstanding shares. This buyback authorization permits the semiconductor company to buy up to 1.1% of its stock through open market purchases. Share buyback plans are generally a sign that the company’s board believes its shares are undervalued.
Synopsys Company Profile
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
Featured Stories
- Five stocks we like better than Synopsys
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
